Joaquı́n Arribas

机构：Institució Catalana de Recerca i Estudis Avançats, Universitat Pompeu Fabra, Hospital Del Mar, Hospital del Mar Research Institute, Centro de Investigación Biomédica en Red de Cáncer, Vall d'Hebron Institute of Oncology · ORCID：0000-0002-0504-0664

发表论文 566 篇 · 总被引 15267 次 · h-index 64

代表论文

The efficacy of chemotherapy is limited by intratumoral senescent cells expressing PD-L2 (2024 · Nature Cancer · 被引 111)
The PARP1 selective inhibitor saruparib (AZD5305) elicits potent and durable antitumor activity in patient-derived BRCA1/2-associated cancer models (2024 · Genome Medicine · 被引 75)
AXL – a new player in resistance to HER2 blockade (2023 · Cancer Treatment Reviews · 被引 25)
Interactions between BRD4S, LOXL2, and MED1 drive cell cycle transcription in triple‐negative breast cancer (2023 · EMBO Molecular Medicine · 被引 15)
ERK 1/2 mitogen‐activated protein kinase dimerization is essential for the regulation of cell motility (2024 · Molecular Oncology · 被引 11)
Generation of chimeric antigen receptor T cells targeting p95HER2 in solid tumors (2024 · Nature Communications · 被引 7)